OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Click here to read the articles and download the PDF
The need for expert strategies to improve rheumatoid arthritis (RA) therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.
New Pharma Commerce column addresses the relevance of pricing.
Post-pandemic conditions are improving for the temperature-controlled market, but, meanwhile, the technical demands are rising.
March 29, 2023
Why deploying AI and analytics in tandem is a key targeting tool.
Why automation-enabling tech—such as NLP and ML—can help improve medicine effectiveness.
March 28, 2023
Facility will provide 240,000 square feet worth of production support to the pharma sector.
March 27, 2023
Senate committee report highlights a lack of visibility in API suppliers.
March 24, 2023
Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.
March 20, 2023
Corey Ford comments on his second PAP presentation, with this one centered around broadening the definition of adherence.
AmerisourceBergen exec explains how his experience in health policy analysis and data analytics helps him tackle patient access obstacles.
AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.
Corey Ford dives into questions brought up during his 'state of the union' presentation.
AmerisourceBergen exec highlights his 'state of the industry' address that he made at day one of the conference.